Medicare Enrolled
Dr. Asad Qamar, M.D.
Cardiovascular Disease · Ocala, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Qamar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qamar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qamar
Dr. Asad Qamar is a cardiovascular disease in Ocala, FL, with 19 years in practice. Based on federal Medicare data, Dr. Qamar performed 15,760 Medicare services across 8,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qamar received a total of $6,397 from 31 pharmaceutical and/or device companies across 242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qamar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $6,397 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,760
Medicare services
Top 3% in FL for cardiovascular disease
8,363
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~829 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,414 | $94 | $165 |
| Infectious disease DNA/RNA test | 1,651 | $34 | $105 |
| Complete blood count (CBC) with differential | 1,004 | $8 | $20 |
| Automated white blood cell count | 629 | $2 | $4 |
| Screening test for mononucleosis (mono) | 509 | $5 | $20 |
| Antibody identification test for white blood cell antibodies | 507 | $15 | $35 |
| Platelet count, automated test | 488 | $4 | $7 |
| Blood count, hemoglobin | 485 | $2 | $20 |
| Urea nitrogen level to assess kidney function, quantitative | 358 | $4 | $6 |
| Red blood cell count, automated test | 342 | $3 | $5 |
| Red blood cell concentration measurement | 340 | $2 | $4 |
| Ultrasound of leg arteries or artery grafts | 291 | $175 | $425 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 289 | $141 | $380 |
| Regadenoson injection (Lexiscan) for heart stress test | 284 | $47 | $75 |
| Echocardiogram, transthoracic | 248 | $138 | $450 |
| Blood glucose (sugar) level | 243 | $4 | $6 |
| Ultrasound of both sides of head and neck blood flow | 237 | $141 | $353 |
| Electrocardiogram (EKG), 12-lead | 228 | $11 | $58 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 219 | $19 | $40 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 219 | $623 | $1,300 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 204 | $134 | $341 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 199 | $69 | $211 |
| Blood draw (venipuncture) | 198 | $8 | $10 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 197 | $47 | $258 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 174 | $87 | $225 |
| Liver enzyme (sgpt), level | 136 | $5 | $8 |
| Albumin (protein) level | 132 | $5 | $7 |
| Bilirubin level, direct | 132 | $5 | $20 |
| Total protein level, blood | 132 | $4 | $6 |
| Basic metabolic blood panel | 129 | $8 | $13 |
| Blood creatinine level | 128 | $5 | $8 |
| Blood gases measurement | 128 | $26 | $39 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 123 | $34 | $70 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 121 | $725 | $1,905 |
| Liver enzyme (sgot), level | 110 | $5 | $8 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 109 | $113 | $428 |
| Amylase (enzyme) level | 106 | $6 | $10 |
| Phosphatase (enzyme) level, alkaline | 106 | $5 | $8 |
| Uric acid level test | 106 | $4 | $7 |
| Review by radiologist of additional artery image | 99 | $76 | $125 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 99 | $47 | $276 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 87 | $322 | $650 |
| Creatine measurement | 78 | $5 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 76 | $9 | $20 |
| New patient office visit (45-59 min) | 76 | $122 | $276 |
| Glutamyltransferase (liver enzyme) level | 74 | $7 | $11 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 70 | $79 | $250 |
| Programming of dual lead pacemaker system | 64 | $59 | $90 |
| Thyroid stimulating hormone (TSH) test | 63 | $16 | $25 |
| Ultrasound of one leg arteries or artery grafts | 62 | $94 | $285 |
| Lipid panel (cholesterol and triglycerides) | 59 | $13 | $40 |
| Insertion of tube into vein, second order branch | 55 | $343 | $1,049 |
| Review by radiologist of arm or leg artery image | 52 | $118 | $522 |
| Review by radiologist of abdominal artery image | 52 | $133 | $297 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 52 | $104 | $265 |
| Review by radiologist of major lower body vein image | 52 | $88 | $443 |
| Insertion of stent in vein with review by radiologist, initial vein | 51 | $2,622 | $5,010 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 48 | $486 | $2,139 |
| Vldl cholesterol level | 48 | $12 | $28 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 48 | $87 | $380 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 45 | $91 | $289 |
| Insertion of stent in vein with review by radiologist, each additional vein | 45 | $1,303 | $2,360 |
| Review by radiologist of both arms or legs arteries image | 42 | $126 | $353 |
| Ultrasound of arm arteries or artery grafts | 38 | $146 | $297 |
| Free thyroxine (T4) test | 36 | $9 | $15 |
| Removal of plaque and insertion of stents in arteries of leg | 34 | $7,517 | $17,412 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | $38 | $75 |
| Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) | 29 | $7 | $7 |
| Hemoglobin a1c level, by device for home use | 29 | $10 | $30 |
| Comprehensive metabolic blood panel | 28 | $10 | $32 |
| Thyroid hormone evaluation | 27 | $6 | $20 |
| Removal of plaque and insertion of stents in artery of leg, initial vessel | 26 | $8,930 | $16,827 |
| Thyroxine (thyroid chemical), total | 26 | $7 | $10 |
| Remote pacemaker/defibrillator monitoring, 90 days | 26 | $17 | $55 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 25 | $13 | $30 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 25 | $34 | $70 |
| Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | 24 | $626 | $3,296 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 23 | $131 | $490 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 22 | $992 | $2,295 |
| Removal of plaque in artery of leg, each additional vessel | 21 | $810 | $2,000 |
| Remote pacemaker monitoring, 90 days | 20 | $23 | $185 |
| Limited ultrasound scan of abdomen | 19 | $57 | $175 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 19 | $190 | $500 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 15 | $176 | $450 |
| Removal of plaque in artery of leg, initial vessel | 14 | $6,281 | $14,214 |
| Insertion of stent in artery (except lower extremity, chest, heart, neck and brain) with review by radiologist, initial artery | 14 | $2,033 | $5,071 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 12 | $1,937 | $3,400 |
| Hemoglobin A1c test (diabetes monitoring) | 12 | $10 | $35 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 12 | $313 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
11.6% medium
84.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,397
Total received (2018-2024)
Avg $914/year across 7 years
Top 33% in FL for cardiovascular disease
31
Companies
242
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,309 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,708
2023$1,036
2022$726
2021$733
2020$327
2019$315
2018$1,551
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BIOTRONIK INC.
$1,529
Medtronic, Inc.
$1,084
Abbott Laboratories
$769
Lundbeck LLC
$704
PFIZER INC.
$331
Janssen Pharmaceuticals, Inc
$319
Boston Scientific Corporation
$286
Amgen Inc.
$187
W. L. Gore & Associates, Inc.
$143
Philips North America LLC
$128
E.R. Squibb & Sons, L.L.C.
$125
Vasorum USA Inc.
$119
Novartis Pharmaceuticals Corporation
$92
AngioDynamics, Inc.
$74
AstraZeneca Pharmaceuticals LP
$68
Merck Sharp & Dohme Corporation
$64
Merck Sharp & Dohme LLC
$60
Novo Nordisk Inc
$59
Cook Medical LLC
$58
Impulse Dynamics (USA) Inc.
$36
ORGANOGENESIS INC.
$25
Medtronic Vascular, Inc.
$20
Bardy Diagnostics, Inc.
$15
Inspire Medical Systems, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
Acerta Pharma LLC
$13
Baxter Healthcare
$13
BOSTON SCIENTIFIC CORPORATION
$12
Philips Electronics North America Corporation
$12
Braemar Manufacturing, LLC
$11
Astellas Pharma US Inc
$11
Top 3 companies account for 52.9% of total payments
Associated products mentioned in payments ›
(6554) Peripheral Vascular Undivided · (P84) IGT Devices Systems · ABRE · AMPLATZER AMULET · AVEIR · Abre · BELSOMRA · BIOMONITOR · BRILINTA · BioMonitor · CAMZYOS · CELT ACD · CLARIA MRI QUAD CRT-D SURESCAN · CONFIRM RX · COOK MEDICAL STENTS · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Corlanor · ELIQUIS · ENTRESTO · EVLT · FARXIGA · GORE VIABAHN Endoprosthesis with Heparin · GORE VIABAHN VBX Balloon Expandable Endo · HawkOne · Hillrom - Cardiac Ambulatory Monitor · INSPIRE · JOT DX · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · MITRACLIP · NORTHERA · OPTIMIZER · OptiCross 35 · Orsiro Mission · Ozempic · Peripheral RotaLink Plus · Puraply Antimicrobial · Ranger · Repatha · TURBOHAWK · Trintellix · TurboHawk · VERQUVO · Varithena Administration Pack · WATCHMAN · WATCHMAN FLX · XARELTO · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $41 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
53
Per 100K population
13.7
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Qamar is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Qamar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Qamar performed 2,414 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qamar receive payments from pharmaceutical companies?
Yes. Dr. Qamar received a total of $6,397 from 31 companies across 242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qamar's costs compare to other cardiovascular diseases in Ocala?
Dr. Qamar's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qamar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Ocala
Browse cardiovascular diseases in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology